A recent meta-analysis disclosed that GLP-1 RA reduced all-cause mortality by 12% and adverse renal outcomes by 17%, reporting a significant reduction in hospital admissions for HF, not evidenced by single trials [3]. This evidence concerns the gene GLP1R and hydrops fetalis.